Kevin C. Kelly, PharmD, BCPS

Article

Investigating Real-World Tolerance and Dose Reductions of Oncology Multikinase Inhibitors in a VA Population

Author:: Kevin C. Kelly, PharmD, BCPS

Publish date: May 8, 2026

The US Department of Veterans Affairs (VA) annually treats around 450,000 veterans with cancer and diagnoses an additional 56,000.

Article

Discontinuation Schedule of Inhaled Corticosteroids in Patients With Chronic Obstructive Pulmonary Disease

Author:: Kevin C. Kelly, PharmD, BCPS

Publish date: December 2, 2023

Long-term use of inhaled corticosteroids is associated with potential adverse effects, but would either rapid or tapered discontinuation result in ...